Corrigendum to "Comparison of [17(20)E]-21-Norpregnene oxazolinyl and benzoxazolyl derivatives as inhibitors of CYP17A1 activity and prostate carcinoma cells growth" [Steroids 129 (2018) 24-34].

Zolottsev, Vladimir A; Tkachev, Yaroslav V; Latysheva, Alexandra S; Kostin, Vladimir A; Novikov, Roman A; Timofeev, Vladimir P; Morozevich, Galina E; Kuzikov, Alexey V; Shumyantseva, Victoria V; Misharin, Alexander Y

Zolottsev, Vladimir A; Tkachev, Yaroslav V; Latysheva, Alexandra S; Kostin, Vladimir A; Novikov, Roman A; Timofeev, Vladimir P; Morozevich, Galina E; Kuzikov, Alexey V; Shumyantseva, Victoria V; Misharin, Alexander Y.

Afiliação

Zolottsev VA; Orekhovich Institute of Biomedical Chemistry, Moscow, Russia.
Tkachev YV; Engelhardt Institute of Molecular Biology RAS, Moscow, Russia.
Latysheva AS; Orekhovich Institute of Biomedical Chemistry, Moscow, Russia.
Kostin VA; Orekhovich Institute of Biomedical Chemistry, Moscow, Russia.
Novikov RA; Engelhardt Institute of Molecular Biology RAS, Moscow, Russia.
Timofeev VP; Engelhardt Institute of Molecular Biology RAS, Moscow, Russia.
Morozevich GE; Orekhovich Institute of Biomedical Chemistry, Moscow, Russia.
Kuzikov AV; Orekhovich Institute of Biomedical Chemistry, Moscow, Russia.
Shumyantseva VV; Orekhovich Institute of Biomedical Chemistry, Moscow, Russia.
Misharin AY; Orekhovich Institute of Biomedical Chemistry, Moscow, Russia.

Steroids ; 136: 93, 2018 08.

Article em En | MEDLINE | ID: mdl-29880207

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Steroids Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Federação Russa País de publicação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google